![Vipin K. Garg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vipin K. Garg
Amministratore Delegato presso
Neostx, Inc.
Patrimonio netto: 1 M $ in data 30/06/2026
Profilo
Vipin K.
Garg is currently Chief Executive Officer & Director at Neostx, Inc. Former positions include President & Chief Executive Officer at OCERA Therapeutics LLC from 2000 to 2011, President, Chief Executive Officer & Director at Neos Therapeutics, Inc. from 2013 to 2018, President & Chief Executive Officer at Tranzyme Pharma, Inc. (Canada), President, Chief Executive Officer & Director at Altimmune, Inc. from 2018 to 2026, Director-Marketing & Technical Services at Sumitomo Pharma Co., Ltd. from 1989 to 1992, Director at The North Carolina Biotechnology Center, Principal at Sumitomo Pharma America, Inc., VP-Product Development & Manufacturing at DNX Corp., Manager-Contract Services at Bio Response, Inc. from 1986 to 1989, Chief Operating Officer at Apex Bioscience, Inc. from 1994 to 2000, and Vice President-Development at DNX Bio-Therapeutics, Inc from 1992 to 1994.
Education includes a doctorate from the University of Adelaide conferred in 1982, a graduate degree from Indian Agricultural Research Institute conferred in 1978, and an undergraduate degree from Chaudhary Charan Singh University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ALTIMMUNE, INC. 0,22% | 31/01/2026 | 424.519 ( 0,22% ) | 1 M $ | 30/06/2026 |
Posizioni attive di Vipin K. Garg
| Società | Posizione | Inizio |
|---|---|---|
Neostx, Inc.
 Neostx, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and commercialize branded products | Amministratore Delegato | - |
Precedenti posizioni note di Vipin K. Garg
| Società | Posizione | Fine |
|---|---|---|
| ALTIMMUNE, INC. | Amministratore Delegato | 01/01/2026 |
| NEOS THERAPEUTICS, INC. | Amministratore Delegato | 27/06/2018 |
| OCERA THERAPEUTICS INC | Amministratore Delegato | 11/11/2013 |
Apex Bioscience, Inc.
 Apex Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the development of patented products based upon hemoglobin and nitric oxide technologies | Direttore operativo | 01/01/2000 |
DNX Bio-Therapeutics, Inc | Corporate Officer/Principal | 01/01/1994 |
Formazione di Vipin K. Garg
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
65
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Sumitomo Pharma Co., Ltd.
 Sumitomo Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and other chemical products | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
DNX Corp.
 DNX Corp. Medical SpecialtiesHealth Technology Provides pre-clinical drug development services to the pharmaceutical and biotechnology industry | Health Technology |
Bio Response, Inc.
 Bio Response, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing and distribution services | Commercial Services |
Neostx, Inc.
Neostx, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and commercialize branded products | Commercial Services |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apex Bioscience, Inc.
Apex Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the development of patented products based upon hemoglobin and nitric oxide technologies | Commercial Services |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Technology Services |
Indian Agricultural Research Institute
 Indian Agricultural Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chaudhary Charan Singh University
 Chaudhary Charan Singh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tranzyme Pharma, Inc. (Canada) | |
DNX Bio-Therapeutics, Inc | |
Altimmune, Inc.
 Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
